827016-64-8 Usage
Molecular Weight
419.36 g/mol The molecular weight is the mass of one mole of the compound, calculated by adding the atomic weights of all the atoms in the molecular formula.
Chemical Structure
An indole ring with a piperidine moiety attached to it The chemical structure describes the arrangement of atoms in the compound, in this case, an indole ring with a piperidine group attached to it.
Medicinal Use
Domperidone is used to treat nausea and vomiting, as well as gastrointestinal motility disorders Domperidone is a medication that is used to treat conditions such as nausea, vomiting and gastrointestinal motility disorders.
Mechanism of Action
Blocks dopamine receptors in the brain Domperidone works by blocking dopamine receptors in the brain, which reduces feelings of nausea and vomiting.
Potential Use
Investigated for its potential use in treating conditions such as gastroparesis and Parkinson's disease Domperidone is being studied for its potential use in treating other conditions such as gastroparesis and Parkinson's disease.
Side Effects
Has been linked to cardiac side effects and should be used with caution Domperidone has been associated with certain side effects, such as cardiac problems, and should be used with caution.
Check Digit Verification of cas no
The CAS Registry Mumber 827016-64-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,7,0,1 and 6 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 827016-64:
(8*8)+(7*2)+(6*7)+(5*0)+(4*1)+(3*6)+(2*6)+(1*4)=158
158 % 10 = 8
So 827016-64-8 is a valid CAS Registry Number.
827016-64-8Relevant academic research and scientific papers
SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR
-
Page/Page column 62, (2010/02/10)
New ligands for the ORL-1 receptor are described, useful for modulating the activity of said receptors in a patient in need thereof, and for preventing and treating illnesses dependent on the stimulation of this receptor. The new compounds conform to structural formula (I), wherein Q is a moiety of formula (II) and R, R0, R1, R2, R3, R4, R5, R6 are further defined in the description.
